Drugs Information: Triptorelin
Basic Information
|
||
| ID | DDInter1880 | |
| Drug Type | small molecule | |
| Molecular Formula | C64H82N18O13 | |
| Molecular Weight | - | |
| Description | Triptorelin is a GnRH agonist indicated for the palliative treatment of advanced prostate cancer. | |
| ATC Classification | L02AE04 | |
| IUPAC Name | (2S)-N-[(2S)-5-Carbamimidamido-1-[(2S)-2-[(Carbamoylmethyl)Carbamoyl]Pyrrolidin-1-Yl]-1-Oxopentan-2-Yl]-2-[(2R)-2-[(2S)-2-[(2S)- | |
| InChI | Inchi=1S/C64H82N18O13/C1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/H3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69)/T44-,45-,46-,47-,48+,49-,50-,51-,52-/M0/S1 | |
| InChI Key | VXKHXGOKWPXYNA-PGBVPBMZSA-N | |
| Canonical SMILES | CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Triptorelin
| Severity level | ID | Name | Mechanism | Detail |
|---|